Literature DB >> 33745269

Chemical Reactivities of Two Widely Used Ruthenium-Based CO-Releasing Molecules with a Range of Biologically Important Reagents and Molecules.

Zhengnan Yuan1, Xiaoxiao Yang1, Yuqian Ye1, Ravi Tripathi1, Binghe Wang1.   

Abstract

Ruthenium-based CO-releasing molecules (CO-RMs), CORM-2 and CORM-3, have been widely used as surrogates of CO for studying its biological effects in vitro and in vivo with much success. However, several previous solution-phase and in vitro studies have revealed the ability of such CO-RMs to chemically modify proteins and reduce aromatic nitro groups due to their intrinsic chemical reactivity under certain conditions. In our own work of studying the cytoprotective effects of CO donors, we were in need of assessing chemical factors that could impact the interpretation of results from CO donors including CORM-2,3 in various in vitro assays. For this, we examined the effects of CORM-2,3 toward representative reagents commonly used in various bioassays including resazurin, tetrazolium salts, nitrites, and azide-based H2S probes. We have also examined the effect of CORM-2,3 on glutathione disulfide (GSSG), which is a very important redox regulator. Our studies show the ability of these CO-RMs to induce a number of chemical and/or spectroscopic changes for several commonly used biological reagents under near-physiological conditions. These reactions/spectroscopic changes cannot be duplicated with CO-deleted CO-RMs (iCORMs), which are often used as negative controls. Furthermore, both CORM-2 and -3 are capable of consuming and reducing GSSG in solution. We hope that the results described will help in the future design of control experiments using Ru-based CO-RMs.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33745269      PMCID: PMC8248650          DOI: 10.1021/acs.analchem.1c00533

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  91 in total

Review 1.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple.

Authors:  F Q Schafer; G R Buettner
Journal:  Free Radic Biol Med       Date:  2001-06-01       Impact factor: 7.376

2.  Reaction-based fluorescent probes for selective imaging of hydrogen sulfide in living cells.

Authors:  Alexander R Lippert; Elizabeth J New; Christopher J Chang
Journal:  J Am Chem Soc       Date:  2011-06-15       Impact factor: 15.419

3.  Styrene-maleic acid copolymer-encapsulated carbon monoxide releasing molecule-2 (SMA/CORM-2) suppresses proliferation, migration and invasion of colorectal cancer cells in vitro and in vivo.

Authors:  Chi Lv; Qi Su; Jun Fang; Hongzhuan Yin
Journal:  Biochem Biophys Res Commun       Date:  2019-10-08       Impact factor: 3.575

4.  Esterase-Sensitive and pH-Controlled Carbon Monoxide Prodrugs for Treating Systemic Inflammation.

Authors:  Xingyue Ji; Zhixiang Pan; Chunjie Li; Ting Kang; Ladie Kimberly C De La Cruz; Lingyun Yang; Zhengnan Yuan; Bowen Ke; Binghe Wang
Journal:  J Med Chem       Date:  2019-03-14       Impact factor: 7.446

5.  Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.

Authors:  James E Clark; Patrick Naughton; Sandra Shurey; Colin J Green; Tony R Johnson; Brian E Mann; Roberta Foresti; Roberto Motterlini
Journal:  Circ Res       Date:  2003-07-03       Impact factor: 17.367

6.  Mitochondrial-Localized Versus Cytosolic Intracellular CO-Releasing Organic PhotoCORMs: Evaluation of CO Effects Using Bioenergetics.

Authors:  Tatiana Soboleva; Hector J Esquer; Stacey N Anderson; Lisa M Berreau; Abby D Benninghoff
Journal:  ACS Chem Biol       Date:  2018-07-05       Impact factor: 5.100

7.  Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism.

Authors:  S Jill James; Shannon Rose; Stepan Melnyk; Stefanie Jernigan; Sarah Blossom; Oleksandra Pavliv; David W Gaylor
Journal:  FASEB J       Date:  2009-03-23       Impact factor: 5.191

8.  A thiol-reactive Ru(II) ion, not CO release, underlies the potent antimicrobial and cytotoxic properties of CO-releasing molecule-3.

Authors:  Hannah M Southam; Thomas W Smith; Rhiannon L Lyon; Chunyan Liao; Clare R Trevitt; Laurence A Middlemiss; Francesca L Cox; Jonathan A Chapman; Sherif F El-Khamisy; Michael Hippler; Michael P Williamson; Peter J F Henderson; Robert K Poole
Journal:  Redox Biol       Date:  2018-06-30       Impact factor: 11.799

9.  Organic carbon monoxide prodrug, BW-CO-111, in protection against chemically-induced gastric mucosal damage.

Authors:  Dominik Bakalarz; Marcin Surmiak; Xiaoxiao Yang; Dagmara Wójcik; Edyta Korbut; Zbigniew Śliwowski; Grzegorz Ginter; Grzegorz Buszewicz; Tomasz Brzozowski; Jakub Cieszkowski; Urszula Głowacka; Katarzyna Magierowska; Zhixiang Pan; Binghe Wang; Marcin Magierowski
Journal:  Acta Pharm Sin B       Date:  2020-08-24       Impact factor: 11.413

10.  Norborn-2-en-7-ones as physiologically-triggered carbon monoxide-releasing prodrugs.

Authors:  Jui Thiang Brian Kueh; Nathan J Stanley; Russell J Hewitt; Laura M Woods; Lesley Larsen; Joanne C Harrison; David Rennison; Margaret A Brimble; Ivan A Sammut; David S Larsen
Journal:  Chem Sci       Date:  2017-05-30       Impact factor: 9.825

View more
  7 in total

Review 1.  Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response.

Authors:  Zhengnan Yuan; Ladie Kimberly De La Cruz; Xiaoxiao Yang; Binghe Wang
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

Review 2.  "CO in a pill": Towards oral delivery of carbon monoxide for therapeutic applications.

Authors:  Xiaoxiao Yang; Wen Lu; Minjia Wang; Chalet Tan; Binghe Wang
Journal:  J Control Release       Date:  2021-09-02       Impact factor: 11.467

3.  Flavonol-Based Carbon Monoxide Delivery Molecule with Endoplasmic Reticulum, Mitochondria, And Lysosome Localization.

Authors:  Livia S Lazarus; C Taylor Dederich; Stephen N Anderson; Abby D Benninghoff; Lisa M Berreau
Journal:  ACS Med Chem Lett       Date:  2022-02-01       Impact factor: 4.632

Review 4.  Carbon Monoxide as a Therapeutic for Airway Diseases: Contrast and Comparison of Various CO Delivery Modalities.

Authors:  Ravi Tripathi; Xiaoxiao Yang; Stefan W Ryter; Binghe Wang
Journal:  Curr Top Med Chem       Date:  2021       Impact factor: 3.570

5.  Adapting decarbonylation chemistry for the development of prodrugs capable of in vivo delivery of carbon monoxide utilizing sweeteners as carrier molecules.

Authors:  Ladie Kimberly De La Cruz; Xiaoxiao Yang; Anna Menshikh; Maya Brewer; Wen Lu; Minjia Wang; Siming Wang; Xingyue Ji; Alyssa Cachuela; Haichun Yang; David Gallo; Chalet Tan; Leo Otterbein; Mark de Caestecker; Binghe Wang
Journal:  Chem Sci       Date:  2021-07-01       Impact factor: 9.969

6.  Activated charcoal dispersion of carbon monoxide prodrugs for oral delivery of CO in a pill.

Authors:  Xiaoxiao Yang; Wen Lu; Minjia Wang; Ladie Kimberly De La Cruz; Chalet Tan; Binghe Wang
Journal:  Int J Pharm       Date:  2022-03-08       Impact factor: 6.510

Review 7.  Carbon monoxide and a change of heart.

Authors:  Louis M Chu; Shazhad Shaefi; James D Byrne; Rodrigo W Alves de Souza; Leo E Otterbein
Journal:  Redox Biol       Date:  2021-11-08       Impact factor: 11.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.